Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

被引：12
作者：
Carmen Puertas, Maria [1 ]
Jose Buzon, Maria [1 ]
Artese, Anna [2 ]
Alcaro, Stefano [2 ]
Menendez-Arias, Luis [3 ,4 ]
Perno, Carlo Federico [5 ]
Clotet, Bonaventura [1 ]
Ceccherini-Silberstein, Francesca [5 ]
Martinez-Picado, Javier [1 ,6 ]
机构：
[1] IrsiCaixa Fdn, Hosp Germans Trias & Pujol, Badalona 08916, Spain
[2] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Catanzaro, Italy
[3] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain
[4] Univ Autonoma Madrid, Madrid, Spain
[5] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[6] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
来源：
JOURNAL OF VIROLOGY | 2009年 / 83卷 / 15期
关键词：
RESISTANCE MUTATIONS; ANTIRETROVIRAL THERAPY; ZIDOVUDINE RESISTANCE; VIROLOGICAL RESPONSE; EXPERIENCED PATIENTS; COMBINATION THERAPY; IN-VITRO; HIV-1; PATTERNS; INHIBITORS;
D O I：
10.1128/JVI.00487-09
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A negative association between polymorphism Leu-214 and type-1 thymidine analogue mutations (TAM1) and a positive association with a clinically favorable virological response to thymidine analogue-based combination antiretroviral therapy have been described. In this study, the impact of Leu-214 on replication capacity and resistance to zidovudine (ZDV) of viruses containing TAM1 or TAM2 was determined. Leu-214 decreased the growth rate of viruses bearing Tyr-215, as well as their resistance to ZDV. This observation was confirmed by structural and molecular modeling data, suggesting a regulatory role for Leu-214 in the emergence and phenotypic resistance of TAM1.
引用
收藏
页码：7434 / 7439
页数：6
相关论文
共 50 条
  • [41] Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodeficiency virus type-1: The effects on the ribonuclease H activity
    Sevilya, Z
    Loya, S
    Duvshani, A
    Adir, N
    Hizi, A
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (01) : 19 - 30
  • [42] Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase
    Gleenberg, Iris Oz
    Herschhorn, Alon
    Goldgur, Yehuda
    Hizi, Amnon
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 458 (02) : 202 - 212
  • [43] INHIBITION OF HEAT INACTIVATION OF REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SEROPOSITIVE SERA
    NAGUMO, T
    TAKEUCHI, Y
    HOSHINO, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (06): : 594 - 600
  • [44] Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis
    Julias, JG
    Boyer, PL
    McWilliams, MJ
    Alvord, WG
    Hughes, SH
    VIROLOGY, 2004, 322 (01) : 13 - 21
  • [45] Mutational analysis of Phe160 within the "palm" subdomain of human immunodeficiency virus type 1 reverse transcriptase
    Gutiérrez-Rivas, M
    Ibáñez, A
    Martínez, MA
    Domingo, E
    Menéndez-Arias, L
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 290 (03) : 615 - 625
  • [46] Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
    Martin, Supang A.
    Cane, Patricia A.
    Pillay, Deenan
    Mbisa, Jean L.
    PATHOGENS, 2021, 10 (09):
  • [47] Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication
    Dorr, Casey R.
    Yemets, Sergiy
    Kolomitsyna, Oksana
    Krasutsky, Pavel
    Mansky, Louis M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 542 - 545
  • [48] Replication of human immunodeficiency virus type 1 from entry to exit
    Lever, Andrew M. L.
    Jeang, Kuan-Teh
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (01) : 23 - 30
  • [49] Replication of human immunodeficiency virus type 1 from entry to exit
    Andrew M. L. Lever
    Kuan-Teh Jeang
    International Journal of Hematology, 2006, 84 : 23 - 30
  • [50] Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors
    Englund, JA
    Raskino, C
    Vavro, C
    Palumbo, P
    Ross, LL
    McKinney, R
    Nikolic-Djokic, D
    Colgrove, RC
    Baker, CJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (01) : 15 - 22
12345